SGA
ALXN

Sector Gamma AS’s Alexion Pharmaceuticals ALXN Stock Holding History

Sector Gamma AS’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50,657
Closed -$7.75M – 41
2021
Q1 		$7.75M Sell
50,657
-97,170
-66% -$15M 1.42% 25
2020
Q4 		$23.1M Sell
147,827
-67,241
-31% -$8.64M 4.4% 7
2020
Q3 		$24.6M Buy
215,068
+42,288
+24% +$4.56M 5.6% 7
2020
Q2 		$19.4M Buy
172,780
+4,277
+3% +$454K 4% 9
2020
Q1 		$15.1M Buy
168,503
+42,339
+34% +$4.16M 3.23% 14
2019
Q4 		$13.6M Buy
126,164
+36,200
+40% +$3.87M 2.19% 18
2019
Q3 		$8.81M Buy
+89,964
New +$10.1M 1.49% 25
2017
Q3 		– Sell
-40,300
Closed -$4.9M – 30
2017
Q2 		$4.9M Buy
+40,300
New +$4.69M 0.71% 26
2017
Q1 		– Sell
-48,500
Closed -$5.93M – 29
2016
Q4 		$5.93M Buy
+48,500
New +$5.93M 1.12% 25

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Sector Gamma AS's ALXN Position: Q2 2021 in Review

Sector Gamma AS sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 50,657 shares — an estimated $7.75M sold.

Sector Gamma AS first reported a position in ALXN in Q4 2016 and held it in 9 quarters. The position peaked at $24.6M in Q3 2020. 707 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Sector Gamma AS reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sector Gamma AS sold 50,657 Alexion Pharmaceuticals shares in Q2 2021, an estimated $7.75M.
  • Sector Gamma AS first reported a position in Alexion Pharmaceuticals in Q4 2016 and held it in 9 quarters.
  • Sector Gamma AS's Alexion Pharmaceuticals position peaked at $24.6M in Q3 2020.
  • 707 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Sector Gamma AS's 13F filing for Q2 2021, filed 4 Aug 2021.